Zenas BioPharma
Immunology medicines for rare diseases
- Sector
- Biotech
- Founded
- 2019
- Latest Form D
- $200M, May 2024
- Total capital
- $384M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $384M
- 2 Form D · last May 2024
- 29 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 31 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$200M
- Private capital raisedForm D · SEC · 1st filing$184M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- HONGBO LUDirectorNamed in SEC Form D filings
- JAKE NUNNDirectorNamed in SEC Form D filings
- JAMES PATRICK BOYLANDirectorNamed in SEC Form D filings
- JAMES PATRICK BOYLANDirectorNamed in SEC Form D filings
- JENNIFER FOXExecutive OfficerNamed in SEC Form D filings
- JOHN JACOB ORLOFFDirectorNamed in SEC Form D filings
Show all 17 people
- JOHN JACOB ORLOFFDirectorNamed in SEC Form D filings
- JOSEPH FARMERExecutive OfficerNamed in SEC Form D filings
- LEON O. MOULDER, JR.Executive Officer, DirectorNamed in SEC Form D filings
- LEON O. MOULDER, JR.Executive Officer, DirectorNamed in SEC Form D filings
- PATRICIA ALLENDirectorNamed in SEC Form D filings
- PATRICK GERALD ENRIGHTDirectorNamed in SEC Form D filings
- PATRICK GERALD ENRIGHTDirectorNamed in SEC Form D filings
- TANYA Z. FISCHERExecutive OfficerNamed in SEC Form D filings
- TANYA Z. FISCHERExecutive OfficerNamed in SEC Form D filings
- TIM XIAODirectorNamed in SEC Form D filings
- TOMAS KISELAKDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 31- PendingMethods And Compositions For Treating Autoimmune Hemolytic Anemia (aiha)USPTOApplication 19367474
- PendingMethods Of Producing ANTI-CD19 AntibodiesUSPTOApplication 19242372
- PendingSTABLE FORMULATIONS FOR TNF-alpha ANTIBODIES AND USES THEREOFUSPTOApplication 19071375
Show all 31 patent records
- Methods And Compositions For Treating Autoimmune Hemolytic Anemia (aiha)Feb 12, 2026 · Application 19367474Pending
- Methods Of Producing ANTI-CD19 AntibodiesDec 18, 2025 · Application 19242372Pending
- STABLE FORMULATIONS FOR TNF-alpha ANTIBODIES AND USES THEREOFSep 11, 2025 · Application 19071375Pending
- Methods And Compositions For Treating Systemic Lupus Erythematous (sle)Jul 17, 2025 · Application 19029006Pending
- Methods And Compositions For Treating Relapsing Multiple SclerosisJul 10, 2025 · Application 19013625Pending
- METHODS AND COMPOSITIONS FOR TREATING IgG4-RELATED DISEASESMar 13, 2025 · Application 18960561Pending
- Treatment Of Warm Autoimmune Hemolytic AnemiaApplication 63726904Pending
- Methods And Compositions For Treating Relapsing Multiple SclerosisApplication 63724759Pending
- STABLE FORMULATIONS FOR TNFa ANTIBODIES AND USES THEREOFApplication 63720874Pending
- Stable Formulations For CTLA4-IG Fusion Proteins And Uses ThereofApplication 63719889Pending
- Treatment Of Warm Autoimmune Hemolytic AnemiaApplication 63713867Pending
- Methods And Compositions For Treating Multiple SclerosisApplication PCTUS2024049552Pending
- Stable Formulations For CTLA4-IG Fusion Proteins And Uses ThereofApplication 63696730Pending
- Methods Of Producing ANTI-CD19 AntibodiesApplication 63661248Pending
- STABLE FORMULATIONS FOR TNFa ANTIBODIES AND USES THEREOFApplication 63658731Pending
- Methods And Compositions For Treating Autoimmune Hemolytic Anemia (aiha)Application PCTUS2024025810Pending
- STABLE FORMULATIONS FOR TNFa ANTIBODIES AND USES THEREOFApplication 63561521Pending
- Methods And Compositions For Treating Systemic Lupus Erythematous (sle)Application 63621961Pending
- Methods And Compositions For Treating Multiple SclerosisApplication 63618762Pending
- Methods And Compositions For Treating Multiple SclerosisApplication 63595992Pending
- Methods And Compositions For Treating Multiple SclerosisApplication 63587401Pending
- Methods And Compositions For Treating IGG4-RELATED DiseasesApplication PCTUS2023067849Pending
- METHODS AND COMPOSITIONS FOR TREATING IgG4-RELATED DISEASESApplication 63497929Pending
- Methods And Compositions For Treating Autoimmune Hemolytic Anemia (aiha)Application 63497936Pending
- Treatment Of Warm Autoimmune Hemolytic AnemiaApplication PCTUS2025053255Pending
- METHODS AND COMPOSITIONS FOR TREATING IgG4-RELATED DISEASESApplication 63386781Pending
- Stable Formulations For CTLA4-IG Fusion Proteins And Uses ThereofApplication PCTUS2025047125Pending
- Methods Of Producing ANTI-CD19 AntibodiesApplication PCTUS2025034206Pending
- STABLE FORMULATIONS FOR TNF a ANTIBODIES AND USES THEREOFApplication PCTUS2025018493Pending
- Methods And Compositions For Treating Systemic Lupus Erythematous (sle)Application PCTUS2025012065Pending
- Methods And Compositions For Treating Relapsing Multiple SclerosisApplication PCTUS2025010690Pending
Related companies, and why
- Allogene TherapeuticsSimilar federal contract value in Biotech · null in contracts
- RayzeBioSimilar federal contract value in Biotech · null in contracts
- ImvaxSimilar federal contract value in Biotech · null in contracts
- ProEncia Biotechnology Inc.Similar federal contract value in Biotech · null in contracts
- Metagenomi Technologies, LLCSimilar federal contract value in Biotech · null in contracts
- Harmony Biosciences II, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .